mitochondrial transporters
Recently Published Documents


TOTAL DOCUMENTS

23
(FIVE YEARS 1)

H-INDEX

8
(FIVE YEARS 0)

Biomolecules ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 141
Author(s):  
Rami Mosaoa ◽  
Anna Kasprzyk-Pawelec ◽  
Harvey R. Fernandez ◽  
Maria Laura Avantaggiati

The mitochondrial citrate/isocitrate carrier, CIC, has been shown to play an important role in a growing list of human diseases. CIC belongs to a large family of nuclear-encoded mitochondrial transporters that serve the fundamental function of allowing the transit of ions and metabolites through the impermeable mitochondrial membrane. Citrate is central to mitochondrial metabolism and respiration and plays fundamental activities in the cytosol, serving as a metabolic substrate, an allosteric enzymatic regulator and, as the source of Acetyl-Coenzyme A, also as an epigenetic modifier. In this review, we highlight the complexity of the mechanisms of action of this transporter, describing its involvement in human diseases and the therapeutic opportunities for targeting its activity in several pathological conditions.



2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Vikas Kumar ◽  
Aneesh Kumar A. ◽  
Rahul Sanawar ◽  
Abdul Jaleel ◽  
T. R. Santhosh Kumar ◽  
...  

Abstract We examined the hitherto unexplored role of mitochondrial transporters and iron metabolism in advancing metabolic and mitochondrial dysfunction in the heart during long term pressure overload. We also investigated the link between mitochondrial dysfunction and fluctuation in mitochondrial transporters associated with pressure overload cardiac hypertrophy. Left ventricular hypertrophy (LVH) was induced in 3-month-old male Wistar rats by constriction of the aorta using titanium clips. After sacrifice at the end of 6 and 15 months after constriction, tissues from the left ventricle (LV) from all animals were collected for histology, biochemical studies, proteomic and metabolic profiling, and gene and protein expression studies. LV tissues from rats with LVH had a significant decrease in the expression of ABCB7 and mitochondrial oxidative phosphorylation (mt-OXPHOS) enzymes, an increased level of lipid metabolites, decrease in the level of intermediate metabolites of pentose phosphate pathway and elevated levels of cytoplasmic and mitochondrial iron, reactive oxygen species (ROS) and autophagy-related proteins. Knockdown of ABCB7 in H9C2 cells and stimulation with angiotensin II resulted in increased ROS levels, ferritin, and transferrin receptor expression and iron overload in both mitochondria and cytoplasm. A decrease in mRNA and protein levels of mt-OXPHOS specific enzymes, mt-dynamics and autophagy clearance and activation of IGF-1 signaling were also seen in these cells. ABCB7 overexpression rescued all these changes. ABCB7 was found to interact with mitochondrial complexes IV and V. We conclude that in chronic pressure overload, ABCB7 deficiency results in iron overload and mitochondrial dysfunction, contributing to heart failure.



2018 ◽  
Vol 293 (11) ◽  
pp. 4213-4227 ◽  
Author(s):  
Magnus Monné ◽  
Lucia Daddabbo ◽  
David Gagneul ◽  
Toshihiro Obata ◽  
Björn Hielscher ◽  
...  




Author(s):  
Andrea L. Gropman ◽  
Belen Pappa ◽  
Nicholas Ah Mew

The urea cycle is the primary nitrogen disposal pathway in humans. The urea cycle requires the coordinated function of six enzymes and two mitochondrial transporters to catalyze the conversion of a molecule of ammonia, the α-nitrogen of aspartate and bicarbonate into urea. Whereas ammonia is toxic, urea is relatively inert, soluble in water, and readily excreted by the kidney in the urine. The accumulation of ammonia and other toxic intermediates of the cycle lead to predominantly neurological sequelae. All of the genes have been identified. The disorders may present at any age from the neonatal period to adulthood, with the more severe patients presenting earlier in life. Patients are at risk for metabolic decompensation throughout life, often triggered by illness, fasting, surgery and postoperative states, peripartum, stress, and increased exogenous protein load. This chapter addresses common somatic and neurological presentation, differential diagnosis, laboratory testing, and treatments.



2016 ◽  
Vol 1857 ◽  
pp. e17-e18
Author(s):  
Jorgina Satrustegui ◽  
Carlos B. Rueda ◽  
Irene Llorente-Folch ◽  
Paloma Gonzalez-Sanchez ◽  
Laura Contreras ◽  
...  


2016 ◽  
Vol 1857 (8) ◽  
pp. 1158-1166 ◽  
Author(s):  
Carlos B. Rueda ◽  
Irene Llorente-Folch ◽  
Javier Traba ◽  
Ignacio Amigo ◽  
Paloma Gonzalez-Sanchez ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document